Business overview and recent performance snapshot

Omega Healthcare Investors (OHI) operates as a real estate investment trust focused on financing skilled nursing and assisted living facilities in the US and UK, with 1,024 operating facilities and 88 operators.

The stock recently closed at $46.13, with a month return of about 1.5% and a past 3 months return around 1.9%, while the 1 year total return stands near 38% and the 5 year total return is close to 94%.

After a modest 1 day share price return of 0.13% and a 7 day share price pullback of 1.79%, the stock still sits on a 1 year total shareholder return of 38.1% and a 5 year total shareholder return of 94%. This suggests that longer term momentum has been stronger than the most recent weekly move.

If Omega Healthcare Investors has you thinking about other opportunities in defensive or income focused areas, it could be a good moment to broaden your search and check out 19 top founder-led companies

With Omega Healthcare Investors trading at $46.13, showing strong multi year total returns and an indicated intrinsic discount near 50%, investors may ask: is there still an opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 6.6% Undervalued

Omega Healthcare Investors' most followed valuation narrative points to a fair value of about $49.38, which sits modestly above the recent $46.13 share price and frames the current upside as relatively measured rather than extreme.

Omega's disciplined balance sheet management and opportunistic use of both debt and equity (with a low leverage ratio at decade lows and largely fixed-rate debt) position the company to pursue high-yield acquisitions and portfolio expansion at accretive rates, supporting long-term AFFO and net earnings growth.

Curious what sits behind that projected fair value? The narrative leans heavily on steady earnings, resilient margins, and a future profit multiple that assumes investors stay comfortable paying up for this profile.

Based on this narrative, Omega Healthcare Investors is modeled using a 7.43% discount rate, with modest revenue assumptions and improving profitability doing most of the heavy lifting for the estimated fair value. Analysts in this framework expect earnings to progress while the P/E multiple in the model stays below the current sector level. This helps explain why the gap to the $46.13 share price is relatively small.

Result: Fair Value of $49.38 (UNDERVALUED)

However, there are clear watchpoints, including tenant credit issues such as the Genesis bankruptcy, as well as potential reimbursement or regulatory shifts that could pressure rent collections and earnings quality.

Next Steps

With mixed signals on valuation, risk, and long term returns, it makes sense to check the facts yourself and move quickly to form your own stance using 5 key rewards and 1 important warning sign.

Looking for more investment ideas?

Do not stop with a single stock; widen your radar now and let a few focused screens surface opportunities you might otherwise miss.

• Zero in on potential mispricings by scanning 51 high quality undervalued stocks that combine attractive pricing with solid fundamentals.
• Strengthen your income plan by checking out 12 dividend fortresses built around companies offering yields of 5% or more.
• Sleep easier by reviewing 72 resilient stocks with low risk scores that score well on resilience and lower overall risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.